Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Straight talk with ... Agnès Saint Raymond


Children require specific formulations of drugs to avoid risks of overdosing and inefficacy. And, with this in mind, earlier this year the Bill & Melinda Gates Foundation gave nearly $10 million to the World Health Organization (WHO) to work with UNICEF to improve medicines for youngsters. Researchers have estimated that 50–90% of medicines for children have not been tested properly—a serious problem, given that roughly a third of the worldwide population is under age 18. The problem is a crucial one, according to Agnès Saint Raymond, head of the Scientific Advice, Paediatrics and Orphan Drugs sector, which handles applications to study medicines in children for the European Medicines Agency (EMEA). Saint Raymond has long advocated for children's health and worked with members of the European Parliament to draft and pass new legislation in 2006 to promote drug development in this area. She spoke with Genevive Bjorn about the future of medicines designed for youngsters.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations


Rights and permissions

Reprints and permissions

About this article

Cite this article

Bjorn, G. Straight talk with ... Agnès Saint Raymond. Nat Med 15, 354–355 (2009).

Download citation

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing